期刊文献+

HIV并HCV和(或)HBV临床及流行病学特点分析 被引量:2

下载PDF
导出
摘要 目的探讨人类免疫缺陷病毒(HIV)感染并乙型肝炎病毒(HBV)和(或)丙型肝炎病毒(HCV)的临床及流行病学特点。方法回顾性分析89例HIV感染并HBV和(或)HCV患者的临床流行病学资料。结果HBV混合感染25例,其中10例出现肝酶升高,6例伴黄疸;HCV混合感染56例,其中22例出现肝酶升高,4例伴黄疸;HIV、HBV、HCV三重感染8例,6例出现肝酶升高,3例出现黄疸。HBV混合感染、HCV混合感染及三重感染对肝酶影响无显著性差异,黄疸发生率三重感染最高,HCV混合感染最低;输血、性传播、单采血浆、不详途径以及吸毒的构成比为48.3%、20.2%、16.9%、10.0%、5.6%。结论HIV患者HCV混合感染发生率高于HBV混合感染;黄疸发生率HCV混合感染最低;性传播途径呈上升趋势。
机构地区 北京地坛医院
出处 《山东医药》 CAS 北大核心 2009年第19期52-53,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

二级参考文献22

  • 1梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658. 被引量:967
  • 2Law WP, Dore GJ, Duncombe CJ, et al. Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort,Thailand, 1996-2001. AIDS, 2003, 17: 2191-2199. 被引量:1
  • 3Sulkowski MS. Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors. Clin Infect Dis,2004, Suppl 2: S90-97. 被引量:1
  • 4Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus,and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet, 2002, 360: 1921-1926. 被引量:1
  • 5Sheng WH, Chen MY, Hsieh SM, et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients Infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis,2004, 38: 1471-1477. 被引量:1
  • 6Law WP, Duncombe C J, Mahanontharit A, et al. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort. AIDS, 2004, 18:1169-1177. 被引量:1
  • 7Thio CL. Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment. Semin Liver Dis, 2003, 23: 125-136. 被引量:1
  • 8Zollner B, Petersen J, Schroter M, et al. 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet, 2001,357: 934-935. 被引量:1
  • 9Cooley L, Ayres A, Bartholomeusz A, et al. Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals. AIDS, 2003, 17: 1649-1657. 被引量:1
  • 10Lascar RM, Gilson RJ, Lopes AR, et al. Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection. J Infect Dis, 2003, 188:1815-1819. 被引量:1

共引文献215

同被引文献11

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部